ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1004

Arthritis Impact at the State and County Level — United States, 2015

Kamil E. Barbour1, Suson Moss2, Janet Croft2, Jennifer M. Hootman3, Louise Murphy4, Kristina Theis2, Yan Wang2, Hua Lu2, Teresa J. Brady1 and Charles G. Helmick2, 1Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 2Centers for Disease Control and Prevention, Atlanta, GA, 3Centers for Disease Control and Prevention, Kennesaw, GA, 4Division of Population Health, Centers for Disease Control and Prevention, Atlanta, GA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: arthritis management, Comorbidity, Physical activity and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: ARHP Epidemiology and Public Health Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Arthritis, a leading cause of disability, affects 54.4 million US adults. By knowing the state and county level arthritis impact, state-level public health professionals can determine appropriate resource allocation, understand existing disparities, and target dissemination of evidence-based interventions that can reduce arthritis impact.

Methods: To summarize the arthritis burden at the state and county-level, we used data from the 2015 Behavioral Risk Factor Surveillance System, an annual, random-digit–dialed landline and cellphone survey that is representative of the noninstitutionalized adult population aged ≥18 years in the 50 states and territories. Arthritis was defined as a “yes” to “Has a doctor or other health professional ever told you that have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?” For each state, we calculated arthritis prevalence overall and among those with specific comorbidities; among adults with arthritis, we estimated the prevalence of arthritis-attributable activity limitation (AAAL), social participation restriction (SPR), severe joint pain (SJP), physical inactivity (PIA), leisure walking (LW), and arthritis management behaviors; the latter category on management was calculated for the 13 states that collected this information. Age-adjusted (standardized to the projected 2000 U.S. population) percentages were calculated for all prevalence estimates shown below.

Results: For the 50 states and DC in 2015, the median prevalence of arthritis was 23.0% (range: 17.2-33.6%). For arthritis-attributable impact measures among adults with arthritis, median (range) prevalence for AAAL was 49.7% (40.4-59.4%); SPR was 19.7% (12.6-30.4%); and SJP was 29.7% (20.3-46.0%). Median (range) prevalence of arthritis among adults with obesity, heart disease, and diabetes was 30.9% (24.6-41.2%), 44.5% (25.6-72.6%), and 37.3% (27.1-53.7%), respectively. Median (range) prevalence of PIA and LW among adults with arthritis was 35.0% (23.1-47.9%) and 48.0% (38.5-59.5%), respectively. For arthritis management, median (range) prevalence of being told to exercise for their arthritis and lose weight if overweight/obese to manage arthritis symptoms was 58.5% (52.3-61.9%) and 44.5% (35.1-53.2%), respectively; median prevalence of attending a self-management education (SME) course was 14.5% (range=9.1-19.0%). Arthritis prevalence varied considerably by county (range: 13.5%-34.8%).

Conclusion: Arthritis was common — particularly among those with comorbid conditions — and varied substantially at both the state and county level. Adults with arthritis have a high prevalence of characteristics that impact quality of life (e.g., AAAL, SPR, and SJP), and a large percentage are PIA and do not participate in LW. Participation in a SME course among adults with arthritis remains low; approximately half of health care providers recommended self-management behaviors. Greater use of evidence-based physical activity and SME interventions could reduce pain and improve function and quality of life for all adults with arthritis including those with comorbidities.


Disclosure: K. E. Barbour, None; S. Moss, None; J. Croft, None; J. M. Hootman, None; L. Murphy, None; K. Theis, None; Y. Wang, None; H. Lu, None; T. J. Brady, None; C. G. Helmick, None.

To cite this abstract in AMA style:

Barbour KE, Moss S, Croft J, Hootman JM, Murphy L, Theis K, Wang Y, Lu H, Brady TJ, Helmick CG. Arthritis Impact at the State and County Level — United States, 2015 [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/arthritis-impact-at-the-state-and-county-level-united-states-2015/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/arthritis-impact-at-the-state-and-county-level-united-states-2015/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology